PharmAbcine has newly appeared among the top searched stocks.


As of 12:30 PM on the 27th, PharmAbcine is trading at 25,900 KRW, down 7.0% from the previous day. This represents a 40.76% increase compared to August 20.

Over the past five days, individual investors have net purchased 189,812 shares, while foreigners and institutions have net sold 152,166 shares and 13,409 shares, respectively.


On August 26, PharmAbcine was a market topic for the second consecutive day with the headline "Strong performance on the second day of the PMC-403 contract manufacturing and development agreement with Samsung Biologics (Samba)."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing